Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Forecast, 2015 – 2021

By Joseph T Pharmaceuticals

According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by 2021, growing at a CAGR of around 10.8 % between 2016 and 2021.Pharmacology is the study of drugs and medicines, including their uses, effects, and characteristic. Generic drugs are chemically identical to their branded counterparts. Although, generic drugs are bioequivalent to branded drugs, they are sold at the significant discount from branded drugs prices.




According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by 2021, growing at a CAGR of around 10.8 % between 2016 and 2021.

Pharmacology is the branch of biology, which deals with the study of drugs, their properties, and their sources. Generic drugs are bioequivalent to branded drugs in quality, dosage form, strength, intended use and route of administration. After the expiry of the patent, same branded drug can be copied and manufactured by any other manufacturer at an affordable cost. The most important advantage of generic drugs is they are less expensive as compared to branded drugs because they are not required to repeat costly clinical trials and pay for marketing, advertising and for promotion. As per FDA rules and regulation for substitution of branded drugs, generic drugs should have the same active ingredient, same administration route, same dosage strength, and form. Nowadays, plenty of anti-diabetic, anti-hypersensitive and antibiotic drugs are available in generic formulations.

The market for the generic drug has been accelerated by increasing number of patent expiration of branded drugs and government initiatives. Moreover, increasing the prevalence of chronic diseases and emerging markets are responsible for the growth of generic drugs market. Furthermore, decreased the cost of the drug is acting as a most important factor for the growth of generic drug market. However, high competition and the shortage of drugs can restrict the growth of generic drug market. In addition, prescription of doctors is largely affecting the growth of generic drug market because doctors are prescribing branded drugs to their patient. However, an untapped and emerging market like India and China are expected to generate more opportunities for generic drug market in the forecast period.

Global Generic Drug Market

Based on the brand classification, generic drug market is segmented as pure generic and branded generic. Branded generic drugs are bioequivalent to the generic drugs, but the difference is they are marketed under another companies brand names. Pure generic drugs segment is dominating the market with high market share.

Based on therapeutic application, the market is segmented as central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others. CNS and Cardiovascular segments are the two largest market segment covered by generic drug market. The cardiovascular segment covers more than 20% of global generic drug market due to a number of patent expiry of cardiovascular drugs. Central Nervous System (CNS) is also an emerging segment with more than 15 % revenue contribution for the year 2015.

Based on the geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is dominating the generic drug market due to high demand and increasing the prevalence of chronic diseases. Asia-Pacific is expected to show noticeable growth during the forecast period. In Asia Pacific, India and China are leading countries in the genetic drug market.

Key operating players for generic drugs market are Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Abbott Healthcare Pvt. Ltd., Actavis Pharmaceuticals and Sun Pharmaceuticals.

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global generic drugs market , 2015 – 2021 (USD Billion)
    • 2.2. Global generic drugs market : Snapshot
  • Chapter 3. Generic Drugs Market – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global generic drugs market Drivers: Impact Analysis
      • 3.3.2. increasing number of patent expiration of branded drugs and government initiatives
      • 3.3.3. increase in prevalence of chronic diseases and emerging markets
    • 3.4. Market Restraints
      • 3.4.1. Global generic drugs market Restraints: Impact Analysis
      • 3.4.2. High competition and shortage of generic drugs.
    • 3.5. Opportunities
      • 3.5.1. Untapped and emerging markets like India and China
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, By Brand segment
      • 3.7.2. Market Attractiveness Analysis, By Therapeutic application segment
      • 3.7.3. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global generic drugs market – Competitive Landscape
    • 4.1. Company Market Share, 2014 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Source Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Product And Regional Expansion
    • 4.3. Product Portfolio
  • Chapter 5. Global generic drugs market – Brand Analysis
    • 5.1. Global generic drugs market : Brand Segment Overview
      • 5.1.1. Global generic drugs market Revenue Share, By Brand Segment, 2015 And 2021
    • 5.2. Pure generic drugs
      • 5.2.1. Global generic drugs market for Pure generic drugs, 2015 – 2021 (USD Billion)
    • 5.3. Branded generic drugs
      • 5.3.1. Global generic drugs market for Branded generic drugs, 2015 – 2021 (USD Billion)
  • Chapter 6. Global generic drugs market – Therapeutic application Analysis
    • 6.1. Global generic drugs market : Therapeutic application Segment Overview
      • 6.1.1. Global generic drugs market Revenue Share, By Therapeutic application Segment, 2015 And 2021
    • 6.2. Central nervous system (CNS)
      • 6.2.1. Global generic drugs market For Central nervous system (CNS), 2015 – 2021 (USD Billion)
    • 6.3. Cardiovascular
      • 6.3.1. Global generic drugs market For Cardiovascular, 2015 – 2021 (USD Billion
    • 6.4. Dermatology
      • 6.4.1. Global generic drugs market For Dermatology, 2015 – 2021 (USD Billion
    • 6.5. Oncology
      • 6.5.1. Global generic drugs market For Oncology, 2015 – 2021 (USD Billion
    • 6.6. Respiratory
      • 6.6.1. Global generic drugs market For Respiratory, 2015 – 2021 (USD Billion
    • 6.7. Others
      • 6.7.1. Global generic drugs market For Others, 2015 – 2021 (USD Billion
  • Chapter 7. Global generic drugs market – Regional Segment Analysis
    • 7.1. Global generic drugs market : Regional Overview
      • 7.1.1. Global generic drugs market Revenue Share, By Region, 2014 And 2020
    • 7.2. North America
      • 7.2.1. North America generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
      • 7.2.2. North America generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.2.3.2. U.S. generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe generic drugs market Revenue, by brand, 2015 – 2021 (USD Billion)
      • 7.3.2. Europe generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.3.3. U.K.
        • 7.3.3.1. U.K. generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.3.3.2. U.K. generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.3.4. France
        • 7.3.4.1. U.K. generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.3.4.2. U.K. generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.3.5. Germany
        • 7.3.5.1. Germany generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.3.5.2. Germany generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific generic drugs market Revenue, by brand, 2015 – 2021 (USD Billion)
      • 7.4.2. Asia Pacific generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.4.3.2. China generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.4.4.2. Japan generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.4.5.2. India generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Generic drugs market Revenue, by brand, 2015 – 2021 (USD Billion)
      • 7.5.2. Brazil
        • 7.5.2.1. Brazil generic drugs market Revenue, by brand classification, 2015 – 2021 , (USD Billion)
        • 7.5.2.2. Brazil generic drugs market Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Teva Pharmaceutical Industries Ltd.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Novartis International AG.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Mylan N.V.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Abbott Healthcare Pvt Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Actavis pharmaceuticals Overview
      • 8.5.1. Financials
      • 8.5.2. Product Portfolio
      • 8.5.3. Business Strategy
      • 8.5.4. Recent Developments
    • 8.6. Sun Pharmaceutical Industries Limited Overview
      • 8.6.1. Financials
      • 8.6.2. Product Portfolio
      • 8.6.3. Business Strategy
      • 8.6.4. Recent Developments

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Generic drugs market  Revenue, 2015 – 2021 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Generic drugs market: Market Attractiveness Analysis, by brand Segment
6. Global Generic drugs market: Market Attractiveness Analysis, by Therapeutic application Segment
7. Global Generic drugs market: Market Attractiveness Analysis, by Regional Segment
8. Company Market Share Analysis, 2015 and 2021
9. Global Generic drugs market  Revenue Share by Brand segment, 2015 and 2021
10. Global generic drugs market For Pure generic drugs, 2015 – 2021 (USD Billion)
11. Global generic drugs market Branded generic drugs, 2015 – 2021 (USD Billion)
12. Global generic drugs market Revenue Share, by Therapeutic application Segment, 2015 And 2021
13. Global generic drugs market For Central nervous system (CNS), 2015 – 2021 (USD Billion)
14. Global generic drugs market For Cardiovascular, 2015 – 2021 (USD Billion)
15. Global generic drugs market For Dermatology, 2015 – 2021 (USD Billion)
16. Global generic drugs market For Oncology, 2015 – 2021 (USD Billion)
17. Global generic drugs market For Respiratory, 2015 – 2021 (USD Billion)
18. Global generic drugs market For Others, 2015 – 2021 (USD Billion)
19. Global Generic drugs market Share, By Region, 2015 – 2021
20. North America Generic drugs market , 2015 – 2021, (USD Billion)
21. Europe Generic drugs market , 2015 – 2021, (USD Billion)
22. Asia Pacific Generic drugs market , 2015 – 2021, (USD Billion)
23. Latin America Generic drugs market , 2015 – 2021, (USD Billion)
24. Middle East & Africa Generic drugs market , 2015 – 2021, (USD Billion)

List of Tables

1. Generic drugs market : Market Snapshot
2. Drivers Of Global Generic drugs market : Impact Analysis
3. Restraints Of Global Generic drugs market : Impact Analysis
4. North America generic drugs market  Revenue, by brand classification, 2015 – 2021 , (USD Billion)
5. North America generic drugs market  Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
6. Europe generic drugs market  Revenue, by brand, 2015 – 2021 (USD Billion)
7. Europe generic drugs market  Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
8. Asia Pacific generic drugs market  Revenue, by brand, 2015 – 2021 (USD Billion)
9. Asia Pacific generic drugs market  Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
10. Latin America generic drugs market  Revenue, by brand, 2015 – 2021 (USD Billion)
11. Latin America generic drugs market  Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)
12. Middle East And Africa Generic drugs market  Revenue, by Brand, 2015 – 2021 (USD Billion)
13. Middle East And Africa generic drugs market  Revenue, by Therapeutic application 2015 – 2021 , (USD Billion)

    * Indicates required field.

    Your Name*

    Your Email*

    Telephone Number*

    Name of company*

    Country Name*

    How can we help you?

    Prove You are Human*

    To use CAPTCHA, you need Really Simple CAPTCHA plugin installed.
    Enter Capcha Image Properly

    [simplehidden rpt_title]
    [simplehidden ip_add]
    [simplehidden src_url]

    Share